Medical researchers have announced the results of an innovative treatment approach that may offer improvement in overall survival in older patients with newly diagnosed glioblastoma while maintaining ...

Following Percheron Therapeutics’ (ASX:PER) trial disappointment yesterday, Mesoblast (ASX:MSB) today announced the joyous ...

Kura Oncology, Inc.'s partnership and promising AML treatment make it a top stock pick with significant upside potential for ...

AIIMS researchers claim to have made significant progress in developing chimeric antigen receptor (CAR) T-cell therapy, ...

City of Hope scientists have identified a protein, YTHDF2, that helps cancer cells evade CAR T cell therapy. They developed a ...

Gilead Sciences GILD announced that its first-in-class Trop-2-directed antibody-drug conjugate, Trodelvy (sacituzumab ...

Scientists have discovered a key protein that helps cancer cells avoid detection by the immune system during a type of ...

New research has found that stimulant drugs and atomoxetine appear to be the best treatments for adults with ADHD - which is ...

Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the “immune imprinting” issue that has ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...